The association of adenocarcinoma and hemosputum in pulmonary malignanciesYAMAUCHI, Setsuko; KUDOH, Shinzoh; KIMURA, Tatsuo et al.Respiration (Basel). 2005, Vol 72, Num 5, pp 499-503, issn 0025-7931, 5 p.Article

EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinibYOSHIMURA, Naruo; KUDOH, Shinzoh; KIMURA, Tatsuo et al.Lung cancer. 2006, Vol 51, Num 3, pp 363-368, issn 0169-5002, 6 p.Article

A Phase 3 Study of Induction Treatment With Concurrent Chemoradiotherapy Versus Chemotherapy Before Surgery in Patients With Pathologically Confirmed N2 Stage IIIA Nonsmall Cell Lung Cancer (WJTOG9903)KATAKAMI, Nobuyuki; TADA, Hirohito; MITSUDOMI, Tetsuya et al.Cancer. 2012, Vol 118, Num 24, pp 6126-6135, issn 0008-543X, 10 p.Article

Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIsTANAKA, Hidenori; KIMURA, Tatsuo; KUDOH, Shinzoh et al.International journal of cancer (Print). 2011, Vol 129, Num 6, pp 1410-1416, issn 0020-7136, 7 p.Article

Dose Escalation and Feasibility Study of Amrubicin Combined With Cisplatin in Previously Untreated Patients With Advanced Non-Small Cell Lung CancerYOSHIMURA, Naruo; KIMURA, Tatsuo; MITSUOKA, Shigeki et al.American journal of clinical oncology. 2013, Vol 36, Num 2, pp 105-109, issn 0277-3732, 5 p.Article

Phase i study of tzt-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week coursesTAMURA, Kenji; NAKAGAWA, Kazuhiko; FUKUOKA, Masahiro et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 2, pp 285-293, issn 0344-5704, 9 p.Article

Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancerFUKUOKA, Masahiro; YANO, Seiji; EEK, Richard et al.Journal of clinical oncology. 2003, Vol 21, Num 12, pp 2237-2246, issn 0732-183X, 10 p.Article

A Phase I Study of Chemoradiotherapy With Use of Involved-Field Conformal Radiotherapy and Accelerated Hyperfractionation for Stage III Non-Small Cell Lung Cancer: WJTOG 3305TADA, Takuhito; CHIBA, Yasutaka; NAKANISHI, Yoichi et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 1, pp 327-331, issn 0360-3016, 5 p.Article

MEN4901/T-0128, a new camptothecin derivative-carboxymethyldextran conjugate, has potent antitumor activities in a panel of human tumor xenografts in nude miceFUJITA, Fumiko; KOIKE, Masako; KUDOH, Shinzoh et al.Clinical cancer research. 2005, Vol 11, Num 4, pp 1650-1657, issn 1078-0432, 8 p.Article

Lack of large intestinal carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine at low doses in rats initiated with azoxymethaneDOI, Kenichiro; WANIBUCHI, Hideki; SALIM, Elsayed I et al.International journal of cancer. 2005, Vol 115, Num 6, pp 870-878, issn 0020-7136, 9 p.Article

A single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901)MURAKAMI, Haruyasu; YAMAMOTO, Nobuyuki; SATOUCHI, Miyako et al.Lung cancer. 2014, Vol 84, Num 1, pp 67-72, issn 0169-5002, 6 p.Article

Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancerMASUDA, Noriyuki; NEGORO, Shunichi; FUKUOKA, Masahiro et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 3, pp 533-542, issn 0344-5704, 10 p.Article

Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer : Results of the west japan thoracic oncology group trial (WJTOG 9904)KUDOH, Shinzoh; TAKEDA, Koji; SETO, Takashi et al.Journal of clinical oncology. 2006, Vol 24, Num 22, pp 3657-3663, issn 0732-183X, 7 p.Article

Activated Akt expression has significant correlation with EGFR and TGF-a expressions in stage I NSCLCMUKOHARA, Toru; KUDOH, Shinzoh; FUKUSHIMA, Shoji et al.Anticancer research. 2004, Vol 24, Num 1, pp 11-17, issn 0250-7005, 7 p.Article

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancerNIHO, Seiji; KUNITOH, Hideo; MATSUI, Kaoru et al.Lung cancer. 2012, Vol 76, Num 3, pp 362-367, issn 0169-5002, 6 p.Article

Randomized Phase III Trial of Platinum-Doublet Chemotherapy Followed by Gefitinib Compared With Continued Platinum-Doublet Chemotherapy in Japanese Patients With Advanced Non―Small-Cell Lung Cancer: Results of a West Japan Thoracic Oncology Group Trial (WJTOG0203)TAKEDA, Koji; HIDA, Toyoaki; SASAKI, Jiichiro et al.Journal of clinical oncology. 2010, Vol 28, Num 5, pp 753-760, issn 0732-183X, 8 p.Article

Phase III Trial Comparing Oral S-1 Plus Carboplatin With Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients With Advanced Non-Small-Cell Lung Cancer: Results of a West Japan Oncology Group StudyOKAMOTO, Isamu; YOSHIOKA, Hiroshige; KUDOH, Shinzoh et al.Journal of clinical oncology. 2010, Vol 28, Num 36, pp 5240-5246, issn 0732-183X, 7 p.Article

Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer : JCOG 9515YOSHIDA, Kimihide; SUGIURA, Takahiko; SAIJO, Nagahiro et al.Lung cancer. 2007, Vol 58, Num 3, pp 362-368, issn 0169-5002, 7 p.Article

Phase II Study of Etoposide and Cisplatin With Concurrent Twice-Daily Thoracic Radiotherapy Followed by Irinotecan and Cisplatin in Patients With Limited-Disease Small-Cell Lung Cancer : West Japan Thoracic Oncology Group 9902SAITO, Hiroshi; TAKADA, Yoshiki; ANDO, Masahiko et al.Journal of clinical oncology. 2006, Vol 24, Num 33, pp 5247-5252, issn 0732-183X, 6 p.Article